Searched for
VIGAMOX
JB Pharma acquires trademark licenses, distribution rights of Novartis eye care portfolio in India for Rs 1089 croreJB will pay Rs 964 crore for the portfolio licensing agreement with Novartis Innovative Therapies AG which the company said is "perpetual i...- Lupin gains 4% on drug launch in USVigamox had US sales of USD 267.9 million (IMS MAT March 2017), the report added.
- Lupin launches generic conjunctivitis treatment medicine in USThe product is produced at Lupin's Pithampur manufacturing facility, it added. The medicine is generic equivalent of Novartis Corp's Vigamo...
- USFDA nods to Indian drugs up 84% in 1 yearInterestingly, the growth came during the period when biggies like Sun Pharma and Dr Reddy's had reduced filings from their plants due to c...
- Despite being on rough end, annual report from US FDA’s OGD shows Indian firms won key approvals in 2015The annual report released by the FDA’s OGD shows Indian companies have won some key approvals in the world’s biggest pharmaceuticals marke...
Load More